GCLC Antikörper (AA 286-315)
Kurzübersicht für GCLC Antikörper (AA 286-315) (ABIN3031077)
Target
Alle GCLC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 286-315
-
Kreuzreaktivität (Details)
- Expected species reactivity: Rat
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 286-315 from the human protein was used as the immunogen for this GCLC antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the GCLC antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the GCLC antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- GCLC (Glutamate-Cysteine Ligase, Catalytic Subunit (GCLC))
-
Andere Bezeichnung
- GCLC
-
Hintergrund
- Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.
-
UniProt
- P48506
-
Pathways
- Cell RedoxHomeostasis
Target
-